Regeneron Pharmaceuticals
REGN
#231
Rank
C$141.67 B
Marketcap
C$1,370
Share price
0.56%
Change (1 day)
38.39%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): C$66.16

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$67.18. In 2025 the company made an earnings per share (EPS) of C$61.66 an increase over its 2024 EPS that were of C$58.45.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$66.167.31%
2025C$61.665.48%
2024C$58.4510.34%
2023C$52.98-8.56%
2022C$57.94-47%
2021C$109.32133.36%
2020C$46.8469.13%
2019C$27.70-14.44%
2018C$32.37100.71%
2017C$16.1331.78%
2016C$12.2438.96%
2015C$8.8172.55%
2014C$5.10-17.55%
2013C$6.19-44.98%
2012C$11.25
2010C-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.55-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.51-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$24.85-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.83-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$3.37-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.33-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA